Skip to main content
ConductScienceScienceDex

Mark T. Miedel

NIH Rank #6917
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9393433Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology

NIH Funding · FY2025

Linked Award Amount
$2M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#6,917
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Mark T. Miedel. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Mark T. Miedel as a PI. Multi-PI records show the full award amount for context.

  • 5U2CTR004863-02U2C
    Qualification of Patient-Derived Biomimetic Liver MPS as Drug Discovery Tools for Drug Metabolism, Toxicity, Drug Efficacy Testing and Clinical Trial Cohort Selection
    University of Pittsburgh
    $1.1M
    award amount
  • 5R01DK135606-02R01
    Implementing A QSP Platform to Predict and Test Drugs for Metabolic Associated Fatty Liver Disease Genetic Variants in an iPSC-cell Based Human Biomimetic Liver Microphysiology System
    University of Pittsburgh
    $598.8K
    award amount
  • 5UH3TR004124-04UH3
    Re-engineering a human 3D liver tissue model for non-alcoholic fatty liver disease for drug screening
    University of Pittsburgh
    $238.5K
    award amount

Award organization

Organizations that administered FY2025 awards listing Mark T. Miedel as a PI.

FY2025 award administered by University of Pittsburgh (PA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of Pittsburgh
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4973
  6. 2024
    Entered Top 25% Nationally
    Ranked #4973
  7. 2025
    R01 Grant Holder
  8. 2026
    $5M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Mark T. Miedel.

Alejandro Soto-gutierrez
University of Pittsburgh
5
shared awards
D. Lansing Taylor
University of Pittsburgh
3
shared awards
Lawrence A Vernetti
University of Pittsburgh
3
shared awards
Mark E Schurdak
University of Pittsburgh
3
shared awards

Explore further

Find collaborators for Mark T. Miedel

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →